Since December 2019, coronavirus disease 2019 (COVID-19) pandemic has spread from
China all over the world and many COVID-19 outbreaks have been reported in long-term care …

Although much progress has been made in cancer treatment, the molecular mechanisms
underlying cancer radioresistance (RR) as well as the biological signatures of radioresistant …

To the Editor, Di Giambenedetto et al. 1 described their experience with intravenous tocilizumab
(TCZ) in treating severe coronavirus disease 2019 (COVID‐19). This adds to several …

The ability of pathogens to sequester iron from their host cells and proteins affects their
virulence. Moreover, iron is required for various innate host defense mechanisms as well as for …

Immune checkpoint blockade therapy has changed prognoses for many melanoma patients.
However, immune responses that correlate with clinical progression of the disease are still …

In this study, we report on the results of SARS-CoV-2 surveillance performed in an area of
Southern Italy for 12 months (from March 2021 to February 2022). To this study, we have …

Background The role of serum ferritin (SF) as a prognostic factor has been analyzed in
patients with myelodysplastic syndromes (MDS) who have undergone hematopoietic stem cell …

Enhanced glycolysis is a hallmark of breast cancer. In cancer cells, the high glycolytic flux
induces carbonyl stress, a damaging condition in which the increase of reactive carbonyl …

Background Monoclonal antibodies (mAbs) and antivirals have been approved for early therapy
of coronavirus disease (COVID-19), however, in the real-life setting, there are difficulties …

Embryonic stem cells (ESCs) are pluripotent cells with indefinite self-renewal ability and
differentiation properties. To function properly and maintain genomic stability, ESCs need to be …